News & Updates
Filter by Specialty:
Show Multimedia Only
Progestin-only contraceptives may pose NAFLD risk among women with GDM history
25 Apr 2025
byJairia Dela Cruz
The use of progestin-only contraceptives may put women with a history of gestational diabetes mellitus (GDM) at risk of nonalcoholic fatty liver disease (NAFLD), as shown in a small prospective study.
Progestin-only contraceptives may pose NAFLD risk among women with GDM history
25 Apr 2025
Is there a need for invasive urodynamics to manage OAB in women?
23 Apr 2025
byAudrey Abella
Augmenting comprehensive clinical assessment (CCA) with invasive urodynamic investigations does not appear to benefit women with refractory overactive bladder (OAB) symptoms in the FUTURE* study presented at EAU25.
Is there a need for invasive urodynamics to manage OAB in women?
23 Apr 2025
3-year RUBY data support add-on dostarlimab as frontline Tx for endometrial cancer
17 Apr 2025
byAudrey Abella
At the second interim analysis of part 1 of the phase III RUBY study, updated duration of response (DoR) findings suggest that women with primary advanced or recurrent endometrial cancer who have achieved a response with the combination regimen comprising dostarlimab and carboplatin-paclitaxel (CP) have substantially improved DoR.
